Updated risk assessments for sudden cardiac death in hypertrophic cardiomyopathy patients with implantable cardioverter-defibrillator

키워드

참고문헌 (59)

1. Elliott P, "Classification of the cardiomyopathies : a position statement from the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases", Eur Heart J, 29, pp.270~276 (2008)
2. Trivedi A, "ICD therapy for primary prevention in hypertrophic cardiomyopathy", Arrhythm Electrophysiol Rev, 5, pp.188~196 (2016)
3. Maron MS, "Enhanced American College of Cardiology", American Heart Association strategy for prevention of sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy, 2019, pp.4, 644~657
4. Maron BJ, "Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy", N Engl J Med, 342, pp.365~373 (2000)
5. Maron BJ, "Hypertrophic cardiomyopathy in adulthood associated with low cardiovascular mortality with contemporary management strategies", J Am Coll Cardiol, 65, pp.1915~1928 (2015)
6. Maron BJ, "Risk stratification and outcome of patients with hypertrophic cardiomyopathy >=60years of age", Circulation, 127, pp.585~593 (2013)
7. Maron BJ, "Management of hypertrophic cardiomyopathy : JACC state-of-the-art review", J Am Coll Cardiol, 79, pp.390~414 (2022)
8. Schinkel AF, "Outcome and complications after implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy : systematic review and meta-analysis", Circ Heart Fail, 5, pp.552~559 (2012)
9. Maron BJ, "Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy", JAMA, 298, pp.405~412 (2007)
10. Vriesendorp PA, "Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy : patient outcomes, rate of appropriate and inappropriate interventions, and complications", Am Heart J, 166, pp.496~502 (2013)
11. O’Mahony C, "The long-term survival and the risks and benefits of implantable cardioverter defibrillators in patients with hypertrophic cardiomyopathy", Heart, 98, pp.116~125 (2012)
12. Ommen SR, "2020 AHA", ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathy : a report of the American College of Cardiology, J Am Coll Cardiol, pp.2020, 76[DOI]
13. Authors, "Task Force members", 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy : the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology(ESC), 2014, pp.35, 2733~2779
14. Wang W, "Prognostic implications of nonsustained ventricular tachycardia in high-risk patients with hypertrophic cardiomyopathy", Circ Arrhythm Electrophysiol, 10, pp.e004604~ (2017)
15. Dong Y, "Validation of the 2020 AHA", ACC risk stratification for sudden cardiac death in Chinese patients with hypertrophic cardiomyopathy, 2021, pp.8, 691653~
16. O’Mahony C, "A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy(HCM risk-SCD)", Eur Heart J, 35, pp.2010~2020 (2014)
17. Spirito P, "Syncope and risk of sudden death in hypertrophic cardiomyopathy", Circulation, 119, pp.1703~1710 (2009)
18. Priori SG, "2015ESC guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death : the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology(ESC). Endorsed by : Association for European Paediatric and Congenital Cardiology(AEPC)", Eur Heart J, 36, pp.2793~2867 (2015)
19. Choi YJ, "Validation of the hypertrophic cardiomyopathy risk-sudden cardiac death calculator in Asians", Heart, 105, pp.1892~1897 (2019)
20. Maron BJ, "Epidemiology of hypertrophic cardiomyopathy-related death : revisited in a large non-referral-based patient population", Circulation, 102, pp.858~864 (2000)
21. Park YM, "Ventricular fibrillation and sudden cardiac arrest in apical hypertrophic cardiomyopathy : two case reports", World J Clin Cases, 9, pp.11102~11107 (2021)
22. Xu J, "MRI T1 mapping in hypertrophic cardiomyopathy : evaluation in patients without late gadolinium enhancement and hemodynamic obstruction", Radiology, 294, pp.275~286 (2020)
23. McLellan AJ, "Diffuse ventricular fibrosis on cardiac magnetic resonance imaging associates with ventricular tachycardia in patients with hypertrophic cardiomyopathy", J Cardiovasc Electrophysiol, 27, pp.571~580 (2016)
24. O’Hara RP, "Personalized computational heart models with T1-mapped fibrotic remodeling predict sudden death risk in patients with hypertrophic cardiomyopathy", Elife, 11, pp.e73325~ (2022)
25. Androulakis AF, "Entropy as a novel measure of myocardial tissue heterogeneity for prediction of ventricular arrhythmias and mortality in post-infarct patients", JACC Clin Electrophysiol, 5, pp.480~489 (2019)
26. Ye Y, "Mean scar entropy by late gadolinium enhancement cardiac magnetic resonance is associated with ventricular arrhythmias events in hypertrophic cardiomyopathy", Front Cardiovasc Med, 8, pp.758635~ (2021)
27. Sedaghat-Hamedani F, "Clinical outcomes associated with sarcomere mutations in hypertrophic cardiomyopathy : a meta-analysis on 7675 individuals", Clin Res Cardiol, 107, pp.30~41 (2018)
28. Coppini R, "Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations", J Am Coll Cardiol, 64, pp.2589~2600 (2014)
29. Moolman JC, "Sudden death due to troponin T mutations", J Am Coll Cardiol, 29, pp.549~555 (1997)
30. Varnava AM, "Hypertrophic cardiomyopathy : histopathological features of sudden death in cardiac troponin T disease", Circulation, 104, pp.1380~1384 (2001)
31. Watkins H, "Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy", N Engl J Med, 332, pp.1058~1064 (1995)
32. Shafaattalab S, "Mechanisms of arrhythmogenicity of hypertrophic cardiomyopathy-associated troponin T(TNNT2)variant I79N", Front Cell Dev Biol, 9, pp.787581~ (2021)
33. Burns C, "Multiple gene variants in hypertrophic cardiomyopathy in the era of next-generation sequencing", Circ Cardiovasc Genet, 10, pp.e001666~ (2017)
34. Girolami F, "Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations", J Am Coll Cardiol, 55, pp.1444~1453 (2010)
35. Sadoul N, "Prospective prognostic assessment of blood pressure response during exercise in patients with hypertrophic cardiomyopathy", Circulation, 96, pp.2987~2991 (1997)
36. Herrera-Rodriguez DL, "Genes frequently associated with sudden death in primary hypertrophic cardiomyopathy", Arch Cardiol Mex, 90, pp.58~68 (2020)
37. Christiaans I, "The yield of risk stratification for sudden cardiac death in hypertrophic cardiomyopathy myosin-binding protein C gene mutation carriers : focus on predictive screening", Eur Heart J, 31, pp.842~848 (2010)
38. Magri D, "Cardiopulmonary exercise test and sudden cardiac death risk in hypertrophic cardiomyopathy", Heart, 102, pp.602~609 (2016)
39. Masri A, "Predictors of longterm outcomes in patients with hypertrophic cardiomyopathy undergoing cardiopulmonary stress testing and echocardiography", Am Heart J, 169, pp.684~692 (2015)
40. Bayonas-Ruiz A, "Cardiopulmonary exercise test in patients with hypertrophic cardiomyopathy : a systematic review and meta-analysis", J Clin Med, 10, pp.2312~ (2021)
41. Magri D, "Heart failure progression in hypertrophic cardiomyopathy : possible insights from cardiopulmonary exercise testing", Circ J, 80, pp.2204~2211 (2016)
42. Lee JM, "The impact of cardiopulmonary exercise-derived scoring on prediction of cardio-cerebral outcome in hypertrophic cardiomyopathy", PLoS One, 17, pp.e0259638~ (2022)
43. Eriksson MJ, "Long-term outcome in patients with apical hypertrophic cardiomyopathy", J Am Coll Cardiol, 39, pp.638~645 (2002)
44. Yamaguchi H, "Hypertrophic nonobstructive cardiomyopathy with giant negative T waves(apical hypertrophy) : ventriculographic and echocardiographic features in 30 patients", Am J Cardiol, 44, pp.401~412 (1979)
45. Kubo T, "Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy", ESC Heart Fail, 8, pp.5022~5030 (2021)
46. Liao MT, "Atrial fibrillation and the risk of sudden cardiac arrest in patients with hypertrophic cardiomyopathy : a nationwide cohort study", EClinicalMedicine, 34, pp.100802~ (2021)
47. Sugrue A, "Utility of T-wave amplitude as a non-invasive risk marker of sudden cardiac death in hypertrophic cardiomyopathy", Open Heart, 4, pp.e000561~ (2017)
48. Biagini E, "Usefulness of electrocardiographic patterns at presentation to predict long-term risk of cardiac death in patients with hypertrophic cardiomyopathy", Am J Cardiol, 118, pp.432~439 (2016)
49. Debonnaire P, "QRS fragmentation and QTc duration relate to malignant ventricular tachyarrhythmias and sudden cardiac death in patients with hypertrophic cardiomyopathy", J Cardiovasc Electrophysiol, 26, pp.547~555 (2015)
50. Akboga MK, "Tp-e interval and Tp-e", QTc ratio as novel surrogate markers for prediction of ventricular arrhythmic events in hypertrophic cardiomyopathy, 2017, pp.18, 48~53
51. Guner A, "Impaired repolarization parameters may predict fatal ventricular arrhythmias in patients with hypertrophic cardiomyopathy(from the CILICIA Registry)", J Electrocardiol, 63, pp.83~90 (2020)
52. Song MK, "Relationship between life-threatening events and electromechanical window in patients with hypertrophic cardiomyopathy : a novel parameter for risk stratification of sudden cardiac death", Heart Rhythm, 19, pp.588~594 (2022)
53. Serri K, "Global and regional myocardial function quantification by two-dimensional strain : application in hypertrophic cardiomyopathy", J Am Coll Cardiol, 47, pp.1175~1181 (2006)
54. Lee HJ, "Supplementary role of left ventricular global longitudinal strain for predicting sudden cardiac death in hypertrophic cardiomyopathy", Eur Heart J Cardiovasc Imaging, 23, pp.1108~1116 (2022)
55. Candan O, "Mechanical dispersion and global longitudinal strain by speckle tracking echocardiography : predictors of appropriate implantable cardioverter defibrillator therapy in hypertrophic cardiomyopathy", Echocardiography, 34, pp.835~842 (2017)
56. Negri F, "Prognostic role of global longitudinal strain by feature tracking in patients with hypertrophic cardiomyopathy : the STRAIN-HCM study", Int J Cardiol, 345, pp.61~67 (2021)
57. Geske JB, "B-type natriuretic peptide and survival in hypertrophic cardiomyopathy", J Am Coll Cardiol, 61, pp.2456~2460 (2013)
58. Minami Y, "B-type natriuretic peptide and risk of sudden death in patients with hypertrophic cardiomyopathy", Heart Rhythm, 15, pp.1484~1490 (2018)
59. Wu G, "N-terminal pro-brain natriuretic peptide and sudden cardiac death in hypertrophic cardiomyopathy", Heart, 107, pp.1576~1583 (2021)

관련 논문AI추천